1. Catalog
  2. 2026 Webinar – Pre-emptive TIPS for Variceal Bleed ...
2026 Webinar – Pre-emptive TIPS for Variceal Bleeding
Create Account
Availability
Registration Required
https://aasld.zoom.us/j/87041423868
Jan 27, 2026 12:00 PM - 2:00 PM ET
Cost
$0.00
Credit Offered
1.25 AMA PRA Category 1 Credits
  • Description
  • Learning Objectives
  • Faculty and Disclosures
  • Privacy Policy
  • Recommended
This webinar will identify the indications, limitations, and the application of TIPS in patients with cirrhosis and variceal bleeding. It will also demonstrate the differences between rescue versus pre-emptive TIPS. This activity is intended for hepatologists, gastroenterologists, interventional radiologists, fellows, trainees and others involved in management of patients with portal hypertension.
Upon completion of this activity, a participant should be able to:

• Identify the indications, limitations and the application of TIPS in patients presenting with variceal bleeding
• Demonstrate the differences between rescue versus pre-emptive TIPS
This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.

The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Virginia Hernandez-Gea, MD, PhD

Marika Rudler,

Juan Gonzalez-Abraldes, MD

Lisa VanWagner, MD, MS

Edward W. Lee
Powered By